Literature DB >> 18279440

Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis.

F Idali1, J Wahlström, C Müller-Suur, A Eklund, J Grunewald.   

Abstract

In pulmonary sarcoidosis, the typical T helper 1-mediated immune response in the lungs has been proposed to be co-ordinated by regulatory T cells; however, their exact role needs to be clarified. We used real-time polymerase chain reaction to study genes involved in regulatory T cell functions in CD4+ T cells isolated from bronchoalveolar lavage fluid (BALF) of patients (n = 24) and healthy subjects (n = 7). The genes included the transcription factor forkhead box P3 (FoxP3), interleukin (IL)-10, transforming growth factor-beta1 and chemokine receptor 2 (CCR2). The same genes were also studied in isolated BALF CD4+ T cell receptor AV2S3+ and AV2S3(-) T cells of patients with lung-restricted AV2S3 T cell expansions (n = 12). Intracellular staining of the FoxP3 protein was performed additionally in 14 patients and nine healthy subjects. mRNA expression of FoxP3, CCR2 and IL-10 was decreased significantly in BALF CD4+ T cells of patients. Flow cytometric analysis of CD4+ T cells also demonstrated a decreased frequency of FoxP3+ cells in the BALF and blood of sarcoidosis patients as well as a reduced intensity (mean fluorescence intensity) of FoxP3 expression in BALF FoxP3+ cells of patients. BALF CD4+AV2S3+ T cells expressed significantly lower levels of FoxP3 and CCR2 mRNA versus BALF CD4+AV2S3- T cells. The main conclusion of our study is that there is a reduced expression of regulatory T cell associated genes in BALF CD4+ T cells in sarcoidosis. In addition, our data suggest an effector function of AV2S3+ lung-accumulated T cells in sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18279440      PMCID: PMC2384071          DOI: 10.1111/j.1365-2249.2008.03609.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  Dynamic regulation of FoxP3 expression controls the balance between CD4+ T cell activation and cell death.

Authors:  Deborah J Kasprowicz; Nathalie Droin; David M Soper; Fred Ramsdell; Douglas R Green; Steven F Ziegler
Journal:  Eur J Immunol       Date:  2005-12       Impact factor: 5.532

2.  Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis.

Authors:  K Katchar; J Wahlström; A Eklund; J Grunewald
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

3.  Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis.

Authors:  F Idali; M Wikén; J Wahlström; H Mellstedt; A Eklund; H Rabbani; J Grunewald
Journal:  Eur Respir J       Date:  2006-03       Impact factor: 16.671

4.  Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosis.

Authors:  J Grunewald; M Berlin; O Olerup; A Eklund
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

5.  Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation.

Authors:  J Grunewald; J Wahlström; M Berlin; H Wigzell; A Eklund; O Olerup
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

6.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

7.  Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.

Authors:  Niels R Veillard; Sabine Steffens; Graziano Pelli; B Lu; Brenda R Kwak; Craig Gerard; Israel F Charo; François Mach
Journal:  Circulation       Date:  2005-08-01       Impact factor: 29.690

Review 8.  CD4+ CD25+ suppressor T cells: more questions than answers.

Authors:  Ethan M Shevach
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

9.  Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis.

Authors:  Ute Oltmanns; Bernd Schmidt; Soeren Hoernig; Christian Witt; Matthias John
Journal:  Exp Lung Res       Date:  2003-07       Impact factor: 2.459

10.  The immune paradox of sarcoidosis and regulatory T cells.

Authors:  Makoto Miyara; Zahir Amoura; Christophe Parizot; Cécile Badoual; Karim Dorgham; Salim Trad; Marianne Kambouchner; Dominique Valeyre; Catherine Chapelon-Abric; Patrice Debré; Jean-Charles Piette; Guy Gorochov
Journal:  J Exp Med       Date:  2006-01-23       Impact factor: 14.307

View more
  29 in total

Review 1.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

2.  T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

Authors:  Edward S Chen; Jan Wahlström; Zhimin Song; Matthew H Willett; Maria Wikén; Rex C Yung; Erin E West; John F McDyer; Ying Zhang; Anders Eklund; Johan Grunewald; David R Moller
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

3.  Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.

Authors:  Douglas G Mack; Allison M Lanham; Michael T Falta; Brent E Palmer; Lisa A Maier; Andrew P Fontenot
Journal:  Am J Respir Crit Care Med       Date:  2010-03-18       Impact factor: 21.405

4.  A case of Graves' disease developing with exacerbation of sarcoidosis.

Authors:  Shinya Makino; Chisako Yagi; Mariko Naka; Sachie Hirose; Masayoshi Fujiwara; Chiho Ohbayashi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

5.  Therapeutic granulocyte and monocyte apheresis (GMA) for treatment refractory sarcoidosis: a pilot study of clinical effects and possible mechanisms of action.

Authors:  H H Olsen; V Muratov; K Cederlund; J Lundahl; A Eklund; J Grunewald
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

6.  Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.

Authors:  Diana Milojevic; Khoa D Nguyen; Diane Wara; Elizabeth D Mellins
Journal:  Pediatr Rheumatol Online J       Date:  2008-12-01       Impact factor: 3.054

7.  No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis.

Authors:  Maria Wikén; Farah Idali; Muntasir Abo Al Hayja; Johan Grunewald; Anders Eklund; Jan Wahlström
Journal:  Respir Res       Date:  2010-09-02

8.  Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution.

Authors:  P Sakthivel; J Grunewald; A Eklund; D Bruder; J Wahlström
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

9.  Development of sarcoidosis following etanercept treatment: a report of three cases.

Authors:  Inger Marie Skoie; Klaus Wildhagen; Roald Omdal
Journal:  Rheumatol Int       Date:  2010-01-09       Impact factor: 2.631

10.  Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency.

Authors:  J Horn; A Manguiat; L J Berglund; V Knerr; F Tahami; B Grimbacher; D A Fulcher
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.